The MAUEC enables the marketing authorization of medicines for which the applicant would otherwise be unable to provide comprehensive data on the efficacy and Safety under normal conditions due to reasons of extreme rarity of the condition, technical impossibility to generate comprehensive knowledge, or ethical constraints.
View this resource Bookmark this resource
Marketing Authorization under Exceptional circumstances
Published by IRDiRC
Regulatory AffairsMarketing AuthorisationExceptional Circumstance